- Home
- IPSC vs ASM Comparison
IPSC vs ASM Comparison
Compare IPSC & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- ASM
- Stock Information
- Founded
- IPSC 2019
- ASM 1968
- Country
- IPSC United States
- ASM Canada
- Employees
- IPSC N/A
- ASM N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- ASM Metal Mining
- Sector
- IPSC Health Care
- ASM Basic Materials
- Exchange
- IPSC Nasdaq
- ASM Nasdaq
- Market Cap
- IPSC 146.2M
- ASM 146.2M
- IPO Year
- IPSC 2021
- ASM N/A
- Fundamental
- Price
- IPSC $1.10
- ASM $0.92
- Analyst Decision
- IPSC Strong Buy
- ASM Strong Buy
- Analyst Count
- IPSC 4
- ASM 2
- Target Price
- IPSC $13.00
- ASM $1.80
- AVG Volume (30 Days)
- IPSC 864.2K
- ASM 1.3M
- Earning Date
- IPSC 11-05-2024
- ASM 11-12-2024
- Dividend Yield
- IPSC N/A
- ASM N/A
- EPS Growth
- IPSC N/A
- ASM 144.19
- EPS
- IPSC N/A
- ASM 0.02
- Revenue
- IPSC $2,684,000.00
- ASM $54,326,000.00
- Revenue This Year
- IPSC $230.56
- ASM $40.31
- Revenue Next Year
- IPSC $31.85
- ASM $33.83
- P/E Ratio
- IPSC N/A
- ASM $36.40
- Revenue Growth
- IPSC 7.88
- ASM 18.08
- 52 Week Low
- IPSC $0.98
- ASM $0.44
- 52 Week High
- IPSC $5.51
- ASM $1.56
- Technical
- Relative Strength Index (RSI)
- IPSC 36.74
- ASM 35.14
- Support Level
- IPSC $0.98
- ASM $0.88
- Resistance Level
- IPSC $1.74
- ASM $1.18
- Average True Range (ATR)
- IPSC 0.14
- ASM 0.06
- MACD
- IPSC -0.04
- ASM -0.02
- Stochastic Oscillator
- IPSC 15.79
- ASM 13.63
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.